Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic
Digestive Diseases · 2023
DOI: 10.1159/000529106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases, 2023. Verfasst von Laura Ramos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Hospital Universitario de Canarias, Universidad de La Laguna, San Cristóbal de La Laguna, Spain. Hauptthemen laut MEDLINE: COVID-19, Inflammatory Bowel Diseases, Telemedicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
During the COVID-19 pandemic, ambulatory clinic visits were replaced by the implementation of telehealth modalities in most inflammatory bowel disease (IBD) units.
Aims
The aim of this study was to assess the efficacy, efficiency, patient satisfaction, and acceptability of using telephone consultation in an IBD unit.
Methods
A prospective cohort study was performed in IBD patients who underwent telephone consultation during COVID-19 lockdown (between 16th March and 13th April 2020). To assess the efficacy of this telephone consultation (lockdown visit), nonscheduled visits, emergency consultation, hospital admission, and surgery from lockdown visit to the next scheduled consultation (post-lockdown) were checked. To evaluate efficiency, the time between lockdown visit and post-lockdown consultation was compared with previous consultation (pre-lockdown), and the total number of visits 12 months before and after lockdown visit was checked. A telephone survey was designed to rate perception for a telephone consultation.
Results
Out of a total of 274 patients, 220 patients (52.2% male; mean age 49 ± 16 years; Crohn’s disease, n = 126; ulcerative colitis, n = 83; indeterminate colitis, n = 11) were included. Only one patient was consulted at the emergency department, 11 patients needed to rearrange the visit, and none patient underwent surgery before the scheduled post-lockdown visit. The interval to post-lockdown visit compared to pre-lockdown visit increased in 37.7% of patients. The satisfaction survey (n = 185) revealed that 94.6% perceived it was effective. However, 44.4% of patients rather prefer on-site consultation for follow-up.
Conclusions
Telemedicine during the COVID-19 pandemic was shown to be effective and efficient to care for IBD patients. In addition, telephone consultation is well accepted by patients in non-extended follow-up periods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Department, Hospital Universitario de Canarias, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
- Departamento de Medicina Interna, Psiquiatría y Dermatología, Instituto Universitario de Tecnologías Biomédicas CIBICAN, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
Zitieren
APA
Ramos, L., Reygosa, C., Carrillo-Palau, M., Alonso-Abreu, I., González-Mendez, Y., de la Barreda, R., Amaral, C., Hernández, A., Benítez-Zafra, F., & Hernandez-Guerra, M. (2023). Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic. Digestive Diseases. https://doi.org/10.1159/000529106
Vancouver
Ramos L, Reygosa C, Carrillo-Palau M, Alonso-Abreu I, González-Mendez Y, de la Barreda R, et al. Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic. Digestive Diseases. 2023. doi:10.1159/000529106
BibTeX
@article{Ramos2023,
author = {Ramos, Laura and Reygosa, Cristina and Carrillo-Palau, Marta and Alonso-Abreu, Inmaculada and González-Mendez, Yanira and de la Barreda, Raquel and Amaral, Carla and Hernández, Anjara and Benítez-Zafra, Federica and Hernandez-Guerra, Manuel},
title = {Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic},
journal = {Digestive Diseases},
year = {2023},
doi = {10.1159/000529106}
}
EUVIMED